Table 2.
ASRS-v1.1 COVs of the overall sample (N = 224) and separated by sex.
| Overall | Sex |
||||
|---|---|---|---|---|---|
| Male | Female | ||||
| n (%) | n (%) | n (%) | χ2 (df) | p-Value | |
| ASRS-6 COV (≥4) | 2.02 (1) | 0.155 | |||
| Exceeded | 77 (34.4) | 55 (37.7) | 22 (28.2) | ||
| Not exceeded | 147 (65.6) | 91 (62.3) | 56 (71.8) | 21.86 (1) | <0.001* |
| ASRS-18 COV (≥12) | 1.75 (1) | 0.185 | |||
| Exceeded | 39 (17.4) | 29 (19.9) | 10 (12.8) | ||
| Not exceeded | 185 (82.6) | 117 (80.1) | 68 (87.2) | 95.16 (1) | <0.001* |
*The percentage of participants who exceeded COVs differed from the percentage of those who did not exceed COVs (*p < 0.05).
χ2, chi-square; df, degrees of freedom; p, p-values. ASRS-6, Adult Attention-Deficit/Hyperactivity Disorder (ADHD) Self-Report Scale, ASRS-v1.1 screener; ASRS-18, Adult ADHD Self-Report Scale, ASRS-v1.1 symptom checklist; COV, cutoff value.